{"id":"W1703213295","doi":"10.2147/dddt.s78036","title":"Spotlight on pembrolizumab in the treatment of advanced melanoma","year":2015,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Melanoma; Metastatic melanoma; Food and drug administration; Immune system; Immunotherapy; Disease; Cancer; Drug; Immune checkpoint; Oncology; Immunology; Cancer research; Internal medicine; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005091771,0.0004244835,0.001291028,0.0002457679,0.00004855628,0.00001618445,0.000147774,0.000135806,0.00003233482],"category_scores_gemma":[0.000003111671,0.0002116213,0.0001970345,0.0003001433,0.00006098422,0.00002495115,0.000005322591,0.0001114492,0.00001043011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002731474,"about_ca_system_score_gemma":0.0006990773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009970238,"about_ca_topic_score_gemma":0.000003863965,"domain_scores_codex":[0.9983765,0.0002239551,0.0005544347,0.0003145309,0.0003064069,0.0002241129],"domain_scores_gemma":[0.9991852,0.0001894119,0.0002186699,0.0003163903,0.00003487384,0.00005542002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002119419,0.0004424245,0.00000823013,0.0004662412,0.0003625231,0.00004027714,0.003632418,9.215763e-8,0.000003826537,0.00001693937,0.0003044834,0.9926031],"study_design_scores_gemma":[0.004998693,0.001121521,0.00008781676,0.002549574,0.00009145744,0.00004324652,0.0001050455,3.175289e-7,0.0002856787,0.00002000829,0.9904679,0.000228763],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002350698,0.9946077,0.00000508735,0.00009544368,0.0001171634,0.002171033,0.000004546778,0.00001731601,0.0006309607],"genre_scores_gemma":[0.000133184,0.9977085,0.0005105703,0.0001357718,0.00005833215,0.0003885332,0.00006392332,0.00003939358,0.0009617895],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9923744,"threshold_uncertainty_score":0.8629667,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08665092685978829,"score_gpt":0.3368170679676156,"score_spread":0.2501661411078273,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}